XM은(는) 미국 국적의 시민에게 서비스를 제공하지 않습니다.

XM은(는) 미국 국적의 시민에게 서비스를 제공하지 않습니다.
P
P

Pfizer

뉴스

Reuters - 2 시간 전

Layoffs pile up in US, Canada as companies uncertain of economy

FACTBOX-Layoffs pile up in US, Canada as companies uncertain of economy Adds Cisco Systems Aug 14 (Reuters) - U.S. and Canadi an companies have continued to cut jobs in 2024 after letting go thousands last year, a s they remain uncertain about t he econom i c conditions . Here is a snapshot of job cuts announced so far this year: TECHNOLOGY * Cisco Systems CSCO.O will lay off 7% of its global workforce , as part of a restructuring plan, the networking giant said, about six months after announcin
A
B
C
C
E
G
I
M
N
N
P
P
S
T
S
E
Reuters - 6 시간 전

AstraZeneca gets $107 mln Pfizer verdict overturned in US cancer drug patent fight

AstraZeneca gets $107 mln Pfizer verdict overturned in US cancer drug patent fight By Blake Brittain Aug 14 (Reuters) - AstraZeneca AZN.L on Wednesday convinced a federal judge in Delaware to throw out a jury's decision that the company owes $107.5 million for infringing cancer-drug patents belonging to Pfizer PFE.N subsidiary Wyeth. U.S. District Judge Matthew Kennelly determined that the two patents Pfizer accused AstraZeneca of infringing with its blockbuster lung-cancer drug Tagrisso were in
A
P
Reuters - 10 시간 전

Big-ticket mergers in the packaged food space over the years

FACTBOX-Big-ticket mergers in the packaged food space over the years Aug 14 (Reuters) - Snickers-maker Mars inked one of the biggest deals in the packaged food industry when it said it would buy Cheez-It owner Kellanova K.N in a $35.9 billion deal on Wednesday. Dealmaking in the packaged food sector has been robust as companies seek scale to weather the impact of price inflation and weight-loss drugs weighing on demand.
D
K
K
M
N
P
K
Reuters - 13 시간 전

Jefferies ups Orion on strong Nubeqa sales

BUZZ-Jefferies ups Orion on strong Nubeqa sales ** Jefferies upgrades Finnish drugmaker Orion ORNBV.HE to "hold" from "underperform" following the recent Nubeqa sales acceleration reported by Bayer BAYGn.DE ** Nubeqa is prostate cancer treatment jointly developed by Orion and Bayer ** Jefferies lifts its estimate for Nubeqa peak sales to 750 millio
B
P
Reuters - 3 일 전

Pfizer Announces Top-Line Results Of Abrysvo For Rsv In Immunocompromised Adults

BRIEF-Pfizer Announces Top-Line Results Of Abrysvo For Rsv In Immunocompromised Adults Aug 12 (Reuters) - Pfizer Inc PFE.N : PFIZER ANNOUNCES TOP-LINE RESULTS OF ABRYSVO FOR RSV IN IMMUNOCOMPROMISED ADULTS PFIZER: STUDY SHOWED ABRYSVO WAS WELL-TOLERATED PFIZER: ABRYSVO GENERATED STRONG NEUTRALIZING RESPONSES AFTER A SINGLE DOSE IN ADULTS ≥ 18 YEA
P
Reuters - 3 일 전

Pfizer's RSV vaccine shows benefit in immuno-compromised adults in study

Pfizer's RSV vaccine shows benefit in immuno-compromised adults in study Aug 12 (Reuters) - Pfizer PFE.N said on Monday its respiratory syncytial virus (RSV) vaccine Abrysvo generated a strong immune response in a late-stage study of four groups of adults aged 18 and older with a compromised immune system. A single 120 microgram dose of the vaccine generated strong neutralizing antibodies against both subtypes of RSV, called RSV-A and RSV-B, across all groups in the study, Pfizer said.
P
Reuters - 6 일 전

Layoffs pile up in US, Canada as companies uncertain of economy

FACTBOX-Layoffs pile up in US, Canada as companies uncertain of economy Adds Paramount Global Aug 9 (Reuters) - Companies in the United States and Canada have continued their job cuts in 2024 after letting go thousands last year, as the outlook on interest rate cuts by the Federal Reserve remains uncertain even as recession fears recede rapidly. Here is a snapshot of job cuts announced so far this year: TECHNOLOGY * Amazon's AMZN.O job cuts include less than 5% of employees at Buy with Prime uni
A
B
C
C
E
G
I
M
N
N
P
P
S
T
S
E
Reuters - 1 주 전

German panel endorses GSK, Pfizer RSV vaccines for elderly

German panel endorses GSK, Pfizer RSV vaccines for elderly FRANKFURT, Aug 8 (Reuters) - Germany's influential vaccine advisory panel said on Thursday that everyone in the country who is 75-years old or more should receive one of two new vaccines against the common respiratory infection RSV. The panel of independent experts known as STIKO said in a statement that one shot, either Pfizer's PFE.N Abrysvo or Arexvy by GSK GSK.L , should be administered ideally in September or October before the cold
A
G
P
S
Reuters - 1 주 전

Viagra-maker Viatris beats Q2 estimates on branded and generic drug demand

Viagra-maker Viatris beats Q2 estimates on branded and generic drug demand Aug 8 (Reuters) - Drugmaker Viatris VTRS.O beat second-quarter profit and revenue estimates on Thursday, driven by strong demand for the Viagra-maker's off-patent branded and generic drugs. Shares of the company were up 3.6% in premarket trade. The Canonsburg, Pennsylvania-based company also raised the 2024 sales outlook for its new product range, including Breyna - a biosimilar to Astrazeneca's AZN.L asthma drug Symbicor
A
P
Reuters - 1 주 전

Novavax cuts 2024 revenue forecast, shrinks European presence

UPDATE 3-Novavax cuts 2024 revenue forecast, shrinks European presence Adds executive comments in paragraphs 3 and 5 By Leroy Leo Aug 8 (Reuters) - Novavax NVAX.O on Thursday trimmed its annual revenue forecast again and said it would pare back its presence in Europe through the rest of the year, ahead of handing over the rights to sell its COVID-19 vaccine to partner Sanofi SASY.PA in 2025. The company's vaccine had failed to make a significant dent in the market share of early COVID-vaccine en
P
S
Reuters - 1 주 전

Third trial over Zantac cancer claims ends with hung jury

UPDATE 1-Third trial over Zantac cancer claims ends with hung jury Adds response from plaintiff's attorney in paragraphs 2-3 By Brendan Pierson Aug 7 (Reuters) - The third trial over claims that discontinued heartburn drug Zantac ended in a mistrial on Wednesday when jurors could not agree about whether pharmaceutical company Boehringer Ingelheim was responsible for an Illinois man's cancer.
G
P
S
Reuters - 1 주 전

Third trial over Zantac cancer claims ends with hung jury

Third trial over Zantac cancer claims ends with hung jury By Brendan Pierson Aug 7 (Reuters) - The third trial over claims that discontinued heartburn drug Zantac ended in a mistrial on Wednesday when jurors could not agree about whether pharmaceutical company Boehringer Ingelheim was responsible for an Illinois man's cancer, according to the plaintiff's lawyer.
G
P
S
Reuters - 1 주 전

Drugmaker Abbott India's Q1 profit climbs on higher sales, price hikes

Drugmaker Abbott India's Q1 profit climbs on higher sales, price hikes BENGALURU, Aug 7 (Reuters) - Drugmaker Abbott India ABOT.NS reported a rise in first-quarter profit on Wednesday, helped by higher sales and price hikes. The company, which makes the popular antacid medicine Digene, said its profit rose to 3.28 billion rupees ($39.1 million) for the quarter ended June 30, a 13% rise from last year.
A
G
P
Reuters - 1 주 전

WPP sells stake in FGS Global to KKR, downgrades guidance

UPDATE 2-WPP sells stake in FGS Global to KKR, downgrades guidance Sells stake of just over 50% for $775 million to partner Downgrades full-year growth forecast to -1% to zero Seeing pressure from smaller clients Adds shares in paragraph 3, more CEO comments in 9-10 By Paul Sandle LONDON, Aug 7 (Reuters) - British ad group WPP WPP.L is selling its controlling stake in financial PR agency FGS Global to minority shareholder KKR for $775 million in cash, which it will use to reduce debt.
P
W
Reuters - 1 주 전

BioNTech sued by UPenn over 19 vaccine patent royalties

BioNTech sued by UPenn over COVID-19 vaccine patent royalties By Blake Brittain Aug 6 (Reuters) - The University of Pennsylvania has sued German biotechnology firm BioNTech 22UAy.DE in Pennsylvania federal court, accusing the company of underpaying royalties for patents covering Penn technology used in BioNTech and Pfizer's PFE.N COVID-19 vaccine Comirnaty.
P
Reuters - 1 주 전

Top of the Street: Sika, Haleon, Anglo American, VAT Group

BUZZ-Top of the Street: Sika, Haleon, Anglo American, VAT Group A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** Stifel raises Swiss chemicals maker Sika SIKA.S to "buy" from "hold" after it increased its PT to CHF 270, which implies an upside of 11%, following the recent share price drop ** Goldman Sachs cuts consumer healthcare company Haleon HLN.L to "neutral" from "buy", as it sees limited catalysts to drive near term price performance, with Pfizer's
D
N
P
S
S
A
Reuters - 1 주 전

GSK wins latest trial over Zantac cancer claims

GSK wins latest trial over Zantac cancer claims By Brendan Pierson Aug 5 (Reuters) - GSK GSK.L won the latest trial over claims that discontinued heartburn drug Zantac caused cancer, as a jury on Monday found that the drug was not responsible for an Illinois woman's illness, a company spokesperson said. Carrie Joiner had alleged in her lawsuit in state court in Chicago that she developed colorectal cancer from a carcinogenic contaminant called NDMA found in the once-blockuster drug.
G
P
S
Reuters - 1 주 전

BioNTech counts on shift to cancer drugs after second quarter losses quadruple

UPDATE 2-BioNTech counts on shift to cancer drugs after second quarter losses quadruple Adds detail on oncology investment, Pfizer outlook BERLIN, Aug 5 (Reuters) - Losses at German drugmaker BioNTech 22UAy.DE quadrupled in the second quarter from a year earlier, the company said on Monday, as it banks on a strategy shift towards new cancer treatments following a sharp drop-off in sales of its COVID-19 vaccine.
P
Reuters - 1 주 전

BioNTech widens loss to 807.8 mln euro in second quarter

BioNTech widens loss to 807.8 mln euro in second quarter BERLIN, Aug 5 (Reuters) - Losses at Germany's BioNTech 22UAy.DE quadrupled year-on-year in the second quarter, the company said on Monday, as it banks on a strategy shift towards new cancer treatments following a sharp drop-off in sales of its COVID-19 vaccine. BioNTech reported a second-quarter net loss of 807.8 million euros ($885.03 million), versus a loss of 190.4 million a year earlier.
P
Reuters - 2 주 전

Layoffs pile up in US, Canada as companies uncertain of economy

FACTBOX-Layoffs pile up in US, Canada as companies uncertain of economy Adds Intel layoffs Aug 2 (Reuters) - Companies in the United States and Canada have continued their job cuts in 2024 after letting go thousands last year, as the outlook on interest rate cuts by the Federal Reserve remains uncertain even as recession fears recede rapidly. Here is a snapshot of job cuts announced so far this year: TECHNOLOGY * Amazon's AMZN.O job cuts include less than 5% of employees at Buy with Prime unit ,
A
B
C
C
E
G
I
M
N
N
P
P
S
T
S
E

조건

인기 자산

면책조항: XM Group 회사는 체결 전용 서비스와 온라인 거래 플랫폼에 대한 접근을 제공하여, 개인이 웹사이트에서 또는 웹사이트를 통해 이용 가능한 콘텐츠를 보거나 사용할 수 있도록 허용합니다. 이에 대해 변경하거나 확장할 의도는 없습니다. 이러한 접근 및 사용에는 다음 사항이 항상 적용됩니다: (i) 이용 약관, (ii) 위험 경고, (iii) 완전 면책조항. 따라서, 이러한 콘텐츠는 일반적인 정보에 불과합니다. 특히, 온라인 거래 플랫폼의 콘텐츠는 금융 시장에서의 거래에 대한 권유나 제안이 아닙니다. 금융 시장에서의 거래는 자본에 상당한 위험을 수반합니다.

온라인 거래 플랫폼에 공개된 모든 자료는 교육/정보 목적으로만 제공되며, 금융, 투자세 또는 거래 조언 및 권고, 거래 가격 기록, 금융 상품 또는 원치 않는 금융 프로모션의 거래 제안 또는 권유를 포함하지 않으며, 포함해서도 안됩니다.

이 웹사이트에 포함된 모든 의견, 뉴스, 리서치, 분석, 가격, 기타 정보 또는 제3자 사이트에 대한 링크와 같이 XM이 준비하는 콘텐츠 뿐만 아니라, 제3자 콘텐츠는 일반 시장 논평으로서 "현재" 기준으로 제공되며, 투자 조언으로 여겨지지 않습니다. 모든 콘텐츠가 투자 리서치로 해석되는 경우, 투자 리서치의 독립성을 촉진하기 위해 고안된 법적 요건에 따라 콘텐츠가 의도되지 않았으며, 준비되지 않았다는 점을 인지하고 동의해야 합니다. 따라서, 관련 법률 및 규정에 따른 마케팅 커뮤니케이션이라고 간주됩니다. 여기에서 접근할 수 있는 앞서 언급한 정보에 대한 비독립 투자 리서치 및 위험 경고 알림을 읽고, 이해하시기 바랍니다.

리스크 경고: 고객님의 자본이 위험에 노출 될 수 있습니다. 레버리지 상품은 모든 분들에게 적합하지 않을수 있습니다. 당사의 리스크 공시를 참고하시기 바랍니다.